28.7 C
Vientiane
Sunday, August 24, 2025
spot_img
Home Blog Page 1211

Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion

MELBOURNE, Australia and INDIANAPOLIS, Ind., Feb. 20, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces its financial results for the year ended 31 December 2024. All figures are in AU$ unless stated otherwise.

FY2024 highlights

  • Total revenue, driven primarily from sales of Illuccix® of $783.2 million, up by 56%1 from $502.5 million in 2023, beating full year guidance2.
  • Second year of profitable growth, delivered in a period of investment, including:
    • R&D investment of $194.6 million, in line with guidance, with a focus on late-stage assets.
    • Expanded global supply chain and product delivery infrastructure, including acquisitions of ARTMS, Inc. and IsoTherapeutics Group, LLC, and expansion of Telix Manufacturing Solutions’ Brussels South facility, resulting in an incremental increase of $15.8 million in manufacturing and distribution investment.
    • Adjusted EBITDA of $99.3 million, up by 70%, demonstrating strong underlying growth3.
  • Telix continued to deliver on its growth strategy. The Company’s key achievements, aligned to its strategic pillars:
    • Grow precision medicine: Prepared for launch of three new products TLX007-CDx (Gozellix®), TLX101-CDx (Pixclara®) and TLX250-CDx (Zircaix®)4 in 2025 while continuing to increase sales and market share for Illuccix®.
    • Deliver late-stage therapeutics: Expanded ProstACT GLOBAL Phase 3 prostate cancer therapy trial recruitment in the U.S. and continued to advance therapeutic trials for the brain and kidney cancer programs.
    • Build next generation pipeline: Delivered clinical proof-of-concept for first alpha therapy candidate in prostate cancer (TLX592) and added depth to urology franchise with acquisition of FAP5-targeting theranostic.
    • Expand global delivery infrastructure: Completed acquisitions of ARTMS, IsoTherapeutics and RLS (USA), Inc. (RLS)6 and expanded Brussels South facility, in preparation to commence GMP7 production in 2025.

For a full list of operational achievements, please refer to the Telix 2024 Annual Report

1.   All comparisons to Full Year 2023 results.

2.   Previously stated guidance of AU$745 million to AU$776 million (US$490 million to US$510 million).

3.   Adjusted EBITDA excludes one-off expenses related to both the Company’s U.S. capital markets activity ($9.1 million) and strategic acquisitions ($8.2 million).

4.   Launch and brand names subject to regulatory approval.

5.   Fibroblast activation protein. Transaction subject to customary closing conditions.

6.   RLS acquisition completed 27 January 2025, subsequent to year end. Refer to ASX disclosure.

7.   Good manufacturing practice.

 

Summary Group financial results

Full Year 2024

Full Year 2023

AU$M

AU$M

% change

Revenue

783.2

502.5

56 %

Cost of sales

(273.6)

(188.2)

45 %

Gross profit

509.6

314.3

62 %

Research and development (R&D)

(194.6)

(128.5)

51 %

Selling and marketing

(85.5)

(50.1)

71 %

Manufacturing and distribution

(25.7)

(9.9)

160 %

General and administration

(129.8)

(74.2)

75 %

Other gains/(losses) (net)

8.1

(35.9)

*

Operating profit

82.1

15.7

423 %

Profit after tax

49.9

5.2

860 %

Adjusted EBITDA1

99.3

58.4

70 %

Cash from operating activities

43.0

23.9

80 %

1. Earnings before interest, tax, depreciation and amortization.

Commentary

Group CEO, Dr. Christian Behrenbruch, commented on the result:

“2024 has been an extraordinary year for Telix. We generated strong financial growth while investing for the future. The Precision Medicine business is poised for step-change growth with three commercial product launches planned for this year in the U.S. and the European rollout of Illuccix. We have a deep therapeutic pipeline with multiple assets moving into pivotal trials, and we are building out the infrastructure to ensure we can deliver our products to patients around the world. We see 2025 as a year of significant growth and evolution for Telix in terms of international business, multiple product launches and the integration of key infrastructure that will further deliver on our mission to ensure global patient access.”

Further details on the Company’s results can be found in the Appendix 4E, investor presentation, and 2024 Annual Report lodged with the ASX and also available on the Company’s website.

Guidance

Telix provides FY2025 revenue guidance of $1.18 billion to $1.23 billion (US$770 million to US$800 million1). This guidance includes revenue from Illuccix (in jurisdictions with a marketing authorization)2 and 11 months of revenue from RLS (and excluding RLS revenue generated from Illuccix). Guidance does not reflect revenue for products that have not yet received a marketing authorization (for example, Gozellix, Pixclara and Zircaix3).

Telix has also provided R&D expenditure guidance, expecting an increased investment range of 20% to 25% compared to FY2024.

lnvestor call

An investor webcast will be held at 9.00am AEDT on Friday 21 February 2025 (5.00pm EST, Thursday 20 February 2025).

Participants can register for the webcast and find audio call details at the following link: https://s1.c-conf.com/ diamondpass/10044775-kmnuu.html

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. ARTMS, IsoTherapeutics, Lightpoint, Optimal Tracers and RLS are Telix Group companies. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX).

Visit www.telixpharma.com for further information about Telix, including details of the latest share price, announcements made to the ASX, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn, X and Facebook.

1.   Conversion to US$ is at an average exchange rate of AU$1 = US$0.65

2.   Does not include European countries for which national phase approval has not yet been granted.

3.   Launch and brand names subject to regulatory approval.

Telix Investor Relations

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications Email: kyahn.williamson@telixpharma.com

Guidance Disclaimer

The stated revenue guidance is based on expected global and domestic economic conditions and is subject to known and unknown risks, uncertainties and other factors that may cause our actual results to differ materially. As such, investors are cautioned not to place undue reliance on this guidance and in particular Telix cannot guarantee a particular result. In compiling financial forecasts, a number of key variables that may have a significant impact on guidance have been identified and are listed below.

Key variables that could cause actual results to differ materially include: the success and timing of research and development activities; decisions by regulatory authorities regarding approval of our products as well as their decisions regarding label claims; competitive developments affecting our products; the ability to successfully market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation or regulations that affect product production, distribution, pricing, reimbursement, access or tax; acquisitions and divestitures; research collaborations; litigation or government investigations; and Telix’s ability to protect its patents and other intellectual property.

This announcement has been authorized for release by the Telix Pharmaceuticals Limited Board of Directors

Legal Notices

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our registration statement on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialisation of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Telix uses various non-IFRS information to reflect its underlying performance. For further information, the reconciliation of non-IFRS financial information to Telix’s statutory measures, reasons for usefulness and calculation methodology, please refer to the Alternative performance measures section in Telix’s Annual Report.

©2025 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals®, Telix Group company, and Telix product names and logos are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. Trademark registration status may vary from country to country.

Bybit FX Insight: Yen Carry Trade Outlook for 2025 and the Future of the Popular Funding Currency

DUBAI, UAE, Feb. 20, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, released a new FX Insight report examining the evolving landscape of the Japanese yen (JPY) carry trade, highlighting significant shifts that could reshape this fundamental trading strategy in 2025. The JPY has maintained its dominance as a funding currency in the FX markets, but this could be the year things start to change.

Figure 1: Japan Statistics Bureau, Bank of Japan (BoJ) and Ministry of Finance reports on inflation and wage growth trends.
Figure 1: Japan Statistics Bureau, Bank of Japan (BoJ) and Ministry of Finance reports on inflation and wage growth trends.

The report, titled “What to Look for in the Yen Carry Trade for 2025,” identifies several crucial developments that traders and investors should monitor:

  • The Japanese yen’s traditional role as a primary funding currency faces new scrutiny amid potential Bank of Japan (BoJ) policy shifts and evolving domestic economic conditions
  • Increased risk of rapid unwinding events due to possible yen strengthening, driven by BoJ monetary tightening or global risk-off scenarios
  • Emergence of alternative funding currencies, including the Swiss franc, euro, and U.S. dollar, reflecting the need for strategic diversification
  • Critical importance of adaptive risk management strategies in response to changing market dynamics

The analysis draws on comprehensive data from multiple authoritative sources, including the Bank of Japan, Federal Reserve, IMF, and Bloomberg Economics, providing traders with actionable insights for navigating this complex trading environment.

Japan’s economic landscape is shifting, with inflation finally breaching the BoJ’s long-standing 2% target, wage growth gaining momentum after years of stagnation, and increasing speculation about potential changes to the BoJ’s monetary policy framework,” the report said, which brings in questions about the yen’s future as a funding currency, “And whether we’re on the cusp of a resurgence in traditional carry trades or facing a structural shift that could redefine global FX strategies.” “In the emerging new era, FX market participants will need to adopt more dynamic strategies, emphasizing robust risk management and diversified approaches.”

The full report includes detailed historical context, current market analysis, and 2025 perspectives on alternative high-yielding currencies such as the Mexican Peso, South African Rand, and Turkish Lira.

To download the complete report and access Bybit’s latest market insights, visit Bybit Learn.

#Bybit / #TheCryptoArk /#BybitResearch

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 60 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

VALORANT Added to HERO ESPORTS Asian Champions League

SHANGHAI, Feb. 20, 2025 /PRNewswire/ — The HERO ESPORTS Asian Champions League (ACL), Asia’s premier multi-title esports tournament hosted by Hero Esports, has officially announced the addition of VALORANT to its inaugural lineup.


Previously, ACL unveiled six game titles: Dota 2, Counter-Strike 2 (CS2), Honor of Kings, Teamfight Tactics, Delta Force, and Crossfire. With VALORANT joining the roster, the total number of games now stands at seven, with more titles expected to be announced soon.

Through continued collaboration with the Esports World Cup, ACL has revealed that the champions of the ACL CS2 and Honor of Kings Tournaments will secure direct entry to the Esports World Cup. Further collaborations on the remaining titles of the ACL are anticipated.

The ACL VALORANT Tournament will be the only international-level VALORANT tournament held in China during the first half of 2025, attracting top teams from overseas. The Final of the event will take place offline in Shanghai. The event will use world-class production and cutting-edge live broadcasting technology to enhance audience experience.

The ACL is set to take place in the first half of 2025, with the Finals of the ACL CS2 Tournament and Honor of Kings Tournament scheduled for May. The ACL will have a total prize pool of $2 million.

Jonny Wang, CEO of the Asian Champions League, said: “We are excited to announce the addition of VALORANT to the ACL. Our ambition is to make ACL into a truly comprehensive tournament, providing a larger stage for players and teams across various competitions while delivering more exciting content for our audience.”

Danny Tang, Co-Founder and CEO of Hero Esports, said: “We are pleased by the progress of the ACL and its ability to attract top teams and titles to compete across Asia. We look forward to the continued collaboration between Hero Esports, ACL and the Esports World Cup Foundation, which is testament to our shared ambition to shape and empower esports globally.”

About Hero Esports

Founded in 2016, Hero Esports is the biggest esports company in Asia, producing more than 7,000 matches every year that captivate an online fan base of over 800 million. With a global presence encompassing 12 office locations and eight top-tier esports arenas, Hero Esports offers a comprehensive suite of esports services, including tournament organization, marketing solutions, community development, and more. As a private company, Hero Esports counts Savvy Games Group and Tencent, among others, as investors, with Kuaishou and Huya as strategic partners.

Headquartered in Shanghai and employing more than 1,100 employees, Hero Esports is a fully integrated operator of esports tournaments and creator of esports content with global reach. The company has helped produce many prestigious tournaments including the Olympic Esports Week, the Esports World Cup as well as the esports series featured at both the Jakarta Asian Games 2018 and the Hangzhou Asian Games 2023. Hero Esports also worked with the world’s top-tier game publishers such as Tencent and Krafton in organizing popular esports leagues such as the Honor of Kings’ KPL series and PUBG’s PGC series, among many others. In 2024, Hero Esports launched Esports Asian Champions League (ACL), Asia’s premier international, multi-title esports tournament. Hero Esports is a member of the Esports Integrity Commission (ESIC).

Innovative Surface Treatment in the Electronics Industry

STEINHAGEN, Germany, Feb. 20, 2025 /PRNewswire/ — Plasmatreat, a leading company in the field of surface treatment with plasma technology, developed the REDOX-Tool: an environmentally friendly, chemical-free solution for removing oxide layers from metal surfaces. This technology brings significant benefits to industries such as automotive, electronics and renewable energy.

Whether power modules, semiconductors or chips - oxide layers can be removed from metal electronic components in a matter of seconds by plasma treatment, thus supporting high-quality and durable end products. (Copyright Plasmatreat GmbH)
Whether power modules, semiconductors or chips – oxide layers can be removed from metal electronic components in a matter of seconds by plasma treatment, thus supporting high-quality and durable end products. (Copyright Plasmatreat GmbH)

The problem of oxide layers
Metal surfaces react when exposed to oxygen, forming unwanted oxide layers that can significantly affect the processing and functionality of components. Particularly in the electronics industry, where components are becoming smaller and more powerful, clean, oxide-free surfaces are essential to ensure the quality and lifetime of the product. Traditional methods for removing these layers are often based on aggressive chemicals and pollute the environment.

The solution: Plasmatreat’s REDOX-Tool
The new REDOX-Tool uses Openair-Plasma – a special form of plasma technology at atmospheric pressure – to clean surfaces precisely, efficiently and without the use of harmful chemicals. The process automatically removes oxide layers, allowing components to be processed immediately. This innovation can speed up production processes, reduce costs and protect the environment.

Easy integration and adaptation
The technology is not only environmentally friendly, but also extremely flexible: the REDOX-Tool can be easily integrated into existing production lines and adapted to different materials or requirements. Whether for the production of semiconductors, lead frames or power modules, the tool offers a solution for many applications and high volumes.

Highest efficiency with smallest components
“With the REDOX-Tool, we are setting new standards in the electronics industry. Even with the smallest components, we achieve outstanding results in oxide removal using environmentally friendly processes,” explains Nico Coenen, Global Director Electronics Market at Plasmatreat GmbH.

Eco-friendly, efficient and future-oriented
The REDOX-Tool combines top performance with sustainability and helps to meet the demands of modern industries. Plasmatreat thus underlines its status as a leading provider of innovative plasma technologies.

What is Openair-Plasma?
Plasma is also known as the 4th state of matter, alongside solids, liquids and gases. When energy is added to a gas, it becomes ionized and enters the energetic (ionized) plasma state. Whether it is plastic, metal, glass or paper, plasma technology is used to modify the properties of the surface to meet the requirements of the process. Subsequent processes include bonding, painting, printing or sealing.

Plasmatreat live at Semicon Korea, Seoul, booth 126 and at IPC Apex, Anaheim, CA, USA, booth 1600. Learn more at: www.plasmatreat.com

Comparison of copper plates treated in the REDOX-Tool (left) and oxidized copper plates (right). The difference between the copper plates without and with oxide layer is clearly visible. (Copyright: Plasmatreat GmbH)
Comparison of copper plates treated in the REDOX-Tool (left) and oxidized copper plates (right). The difference between the copper plates without and with oxide layer is clearly visible. (Copyright: Plasmatreat GmbH)

 

 

Autohome Inc. Announces Change in Controlling Shareholder and Management Change

BEIJING, Feb. 20, 2025 /PRNewswire/ — Autohome Inc. (NYSE: ATHM; HKEX: 2518) (“Autohome” or the “Company”), the leading online destination for automobile consumers in China, today announced that the Company has been informed by Yun Chen Capital Cayman (“Yun Chen“, a subsidiary of Ping An), its controlling shareholder, that on February 20, 2025, Yun Chen entered into a share sale and purchase agreement (the “Share Sale and Purchase Agreement”) with CARTECH HOLDING COMPANY, a subsidiary of Haier Group Corporation (the “Purchaser”). Pursuant to the Share Sale and Purchase Agreement, Yun Chen has agreed to sell, and the Purchaser has agreed to acquire, 200,884,012 ordinary shares of the Company, representing approximately 41.91%[1] of the issued and outstanding ordinary shares of the Company, at a consideration of approximately US$1.8 billion (the “Share Transfer”).

The Share Transfer shall be completed upon satisfaction of the conditions precedent set out in the Share Sale and Purchase Agreement, including, without limitation, obtaining the necessary regulatory approvals. Upon the completion of the Share Transfer, Yun Chen will hold 23,916,500 ordinary shares of the Company, and Yun Chen will cease to be the controlling shareholder of the Company.

The directors of our Company do not expect that the Share Transfer, if completed, will have any material adverse impact on the financial position and business operation of the Company.

The Company further announces that Mr. Tao Wu has resigned from his positions as an executive director and the chief executive officer (the “Chief Executive Officer”) of the Company, effective February 20, 2025. The Company would like to take the opportunity to express its sincere gratitude to Mr. Wu for his valuable contribution to the Company during his tenure.

Furthermore, the Company is pleased to announce that Mr. Song Yang has been appointed as an executive director of the Company and the Chief Executive Officer, effective February 20, 2025. The directors of our Company determined that Mr. Yang has valuable and relevant qualifications and experience, and it is in the best interests of the Company to appoint Mr. Yang as an executive director of the Company and the Chief Executive Officer.  

Mr. Yang has over 20 years of experience in automotive industry in both China and the U.S. Since he joined Autohome in October 2021, Mr. Yang has served as Senior Vice President overseeing OEM business, new retail business, used car business, and TTP Car Inc.. Before joining Autohome, Mr. Yang held different leadership positions at multiple automakers. From April 2019 to September 2021, he worked at Ford China, serving as President of NDSD (National Distribution & Service Division) and Deputy General Manager of the Passenger Vehicle Division. Prior to that, he served as CEO of Borgward Passenger Vehicle Group and the Chairman of its North American R&D Center from February 2018 to February 2019. He held several key leadership positions in marketing and sales at Dongfeng Nissan and NNA (Nissan North America) from May 2005 to December 2014. Mr. Yang received his bachelor’s degree in economics from Fudan University in July 1995.

Mr. Quan Long, the chairman of the Board, stated, “We are delighted to welcome Mr. Song Yang to join in the Board as our executive director and Chief Executive Officer. Mr. Yang has been working in automotive industry both in China and overseas markets for more than 20 years, where he played different crucial leading roles in multiple important automakers. We strongly believe that his leadership and extensive industry experience will be a great asset to the future development of Autohome. The Company looks forward to working with him closely in the future.”

Mr. Long continued, “On behalf of the Board, I would like to express our sincere gratitude to Mr. Wu for his professional dedication and contributions to the Company. We wish him continued success in all of his future endeavors.”

About Autohome Inc.

Autohome Inc. (NYSE: ATHM; HKEX: 2518) is the leading online destination for automobile consumers in China. Its mission is to relentlessly reduce auto industry decision-making and transaction costs driven by advanced technology. Autohome provides occupationally generated content, professionally generated content, user-generated content, and AI-generated content, a comprehensive automobile library, and extensive automobile listing information to automobile consumers, covering the entire car purchase and ownership cycle. The ability to reach a large and engaged user base of automobile consumers has made Autohome a preferred platform for automakers and dealers to conduct their advertising campaigns. Further, the Company’s dealer subscription and advertising services allow dealers to market their inventory and services through Autohome’s platform, extending the reach of their physical showrooms to potentially millions of internet users in China and generating sales leads for them. The Company offers sales leads, data analysis, and marketing services to assist automakers and dealers with improving their efficiency and facilitating transactions. Autohome operates its “Autohome Mall,” a full-service online transaction platform, to facilitate transactions for automakers and dealers. Further, through its websites and mobile applications, it also provides other value-added services, including auto financing, auto insurance, used car transactions, and aftermarket services. For further information, please visit https://www.autohome.com.cn.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will”, “expects”, “anticipates”, “future”, “intends”, “plans”, “believes”, “estimates” and similar statements. Statements that are not historical facts, including statements about Autohome’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement. Further information regarding these and other risks is included in Autohome’s filings with the SEC and announcements on the website of the Hong Kong Stock Exchange. All information provided in this press release is as of the date of this press release, and Autohome does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

Autohome Inc.
Sterling Song
Investor Relations Director  
Tel: +86-10-5985-7483
E-mail: ir@autohome.com.cn 

Christensen China Limited
Suri Cheng
Tel: +86-185-0060-8364
E-mail:  suri.cheng@christensencomms.com 

 

[1] Based on 479,288,580 issued and outstanding ordinary shares of the Company (excluding 30,099,020 treasury shares and ordinary shares that had been issued and reserved for the purpose of the share incentive plans of the Company) as at December 31, 2024.

 

BrightSparks Scholarship & Higher Education Fair 2025 Sees Significant Growth in Attendance, Surpassing Previous Year’s Numbers

  • The BrightSparks Scholarship & Higher Education Fair 2025 attracted 1,108 attendees, nearly doubling last year’s edition.
  • Aligned with this year’s theme, “Be YOU,” the fair inspired students to take charge of their future by discovering scholarships and higher education opportunities that match their passions and ambitions.

SINGAPORE, Feb. 20, 2025 /PRNewswire/ — BrightSparks, Singapore’s leading scholarship and higher education portal, announced the successful culmination of its Scholarship & Higher Education Fair 2025 (SHEF’25). The event, held at Summit 1, Suntec Singapore Convention & Exhibition Centre, attracted 1,108 participants from junior colleges, polytechnics, and universities across Singapore —nearly doubling last year’s turnout of 600 participants. This marked BrightSparks’ second in-person fair since 2018, reinforcing its position as the go-to platform for scholarships and higher education opportunities in Singapore.

Highlights from the BrightSparks Scholarship & Higher Education Fair 2025
Highlights from the BrightSparks Scholarship & Higher Education Fair 2025

The fair, timed to coincide with the release of A-level results on 21 February 2025, provided students with essential guidance on making well-informed decisions about higher education and scholarship opportunities.

“The strong turnout at this year’s fair reflects the growing need for accessible, high-quality guidance as students prepare for the next big step in their education journey,” said Vinay Dua, Managing Director of Kariera Group Singapore. “BrightSparks continues to play a vital role in connecting students with scholarship providers and universities, equipping them with the knowledge and resources needed to make informed and impactful decisions about their future.”

Engaging Discussions and Expert Insights

At SHEF’25, students gained valuable insights into scholarship and higher education opportunities through one-on-one consultations and a series of engaging discussions. Key topics covered included selecting the right scholarships, navigating competitive applications, and aligning academic pursuits with career goals. These discussions empowered students to gain clarity on their aspirations, enabling them to make well-informed decisions about their futures.

“I wanted to learn about the internship and scholarship opportunities offered by HTX (Home Team Science and Technology Agency),” shared Zhang Hong Liang, a final-year junior college student awaiting his A-level results. “This scholarship not only allows me to contribute to protecting our community, but it also gives me the chance to innovate and help make Singapore safer. I really enjoyed the talks, as they provided in-depth information beyond brochures and offered valuable personal perspectives.”

The fair featured a diverse range of exhibitors, including prestigious universities such as University College London and Imperial College London, as well as government agencies such as Home Team Science and Technology Agency, Enterprise Singapore, SkillsFuture Singapore and Workforce Singapore, and Land Transport Authority.

Here’s what some exhibitors had to say:

“We were heartened to meet so many students who are ready to make an impact in the future of land transport. We look forward to nurturing generations of land transport professionals who will be driving the innovations in our sector!” – LTA Scholarship Team

“We were delighted to engage with the students and undergraduates at the fair through our speaker session and one-on-one interactions, sharing how they could be part of SkillsFuture Singapore and Workforce Singapore to contribute to and drive the growth of Singapore’s jobs and skills landscape.” – SSG and WSG Scholarship Team

The fair was a great platform for HTX to interact with aspiring young talents from various levels who are passionate about S&T and innovation, and for us to showcase the diverse career, scholarships, and internship opportunities we offer. – HTX

For the full list of exhibitors, refer to Annex 1.

About BrightSparks

BrightSparks (www.brightsparks.com.sg) by Kariera Group Singapore is Singapore’s #1 Scholarship and Higher Education portal, providing students from Junior Colleges (JC), Polytechnics, and Universities with comprehensive resources for their scholarship and education needs. Established in 2004, BrightSparks connects aspiring scholars to top scholarship providers and organizes premier events like the BrightSparks Scholarship & Higher Education Fair. Additionally, it publishes the biannual BrightSparks magazine and produces the annual BrightSparks Scholarship & Education Survey Report, offering in-depth insights into students’ higher education preferences and aspirations.

Annex 1

List of Exhibitors

  • Enterprise Singapore
  • Home Team Science and Technology Agency
  • SkillsFuture Singapore and Workforce Singapore
  • Land Transport Authority
  • National Environment Agency
  • PUB, Singapore’s National Water Agency
  • Singapore Food Agency
  • Imperial College London
  • UCL (University College London)
  • University of Western Australia
  • University of Plymouth
  • Southern Utah University
  • James Cook University
  • National Trades Union Congress
  • Exeter University
  • Tetr College of Business

 

Huawei APAC Eco Partner Summit 2025: Focusing on Intelligent Ecosystem and Global Business Win-Win

KUALA LUMPUR, Malaysia , Feb. 20, 2025 /PRNewswire/ — Huawei successfully hosted the Huawei APAC Eco Partner Summit 2025 on 18 February at the Malaysia International Trade and Exhibition Centre (MITEC), attracting over 160 ecosystem partners from more than 5 Asia Pacific countries, including 35 CXOs and 25 senior directors. 13 industry experts engaged in in-depth discussions on 8 key topics. Chin Chee Seong, President of the SME Association of Malaysia, shared valuable insights and business trends in the ASEAN market. Representatives from Trip.com, ReelShort, Tencent, Sega, The Gaming Company, Clicktouch and others collaborated to shape the future of the intelligent ecosystem.

Building an Open Ecosystem Platform for Digital Transformation

The summit highlighted culture, tourism, mobile gaming, short drama and cross-border commerce. 13 industry leaders from China, Malaysia, Singapore, Thailand, Philippines and Japan shared practical case studies and experiences. Huawei also debuted its innovative triple-fold smartphone, featuring advanced hinge technology and flexible screens which attracted significant industry attention.

Lv Luping, President of Huawei Consumer BG Asia Pacific Business Department, stated, “The Asia Pacific region is a core market in Huawei’s global strategy. In 2024, Huawei’s global consumer business led the market, with significant growth in early 2025, particularly in foldable screen products. We prioritize user needs, HUAWEI AppGallery and Game Center serve millions of Huawei users daily in APAC region providing a wide range of app content and great gaming experience.” He further emphasized Huawei’s commitment to strengthening local teams, collaborating with partners and enhancing user engagement.


Empowering Chinese Enterprises for Overseas Expansion

Jia Lihui, Senior Manager at Trip.com, shared their successful collaboration with the Huawei ecosystem, demonstrating significant user growth through app listings and advertising. Aubrey from Crazy Maple Studio shared the success story of the short drama platform ‘ReelShort’, highlighting the HUAWEI AppGallery’s support in distributing content to users. Huawei provided comprehensive brand support, including KOL collaborations, social media promotions and on-ground activities, driving mutual success for short dramas and brands.

Promoting Global Business Win-Win

Wu Hao, Vice President of Global Ecosystem Development and Sales at Huawei Consumer Cloud Service, elaborated on Huawei’s global strategy, “Establishing a global healthy ecosystem can we truly create value for users. In 2025, we will continue to innovate and establish dedicated ecological technology teams to quickly respond to partners’ requirements, ensure end-user experience outside China and bring more opportunities to partners. Relying on our global compliance and operational capabilities, we will help overseas local brands penetrate the Chinese market and provide users with convenient and high-quality experiential services by using intelligent atomic-services.”


About Huawei Mobile Services

Huawei Mobile Services is committed to building a “Global Digital Ecosystem Platform” with 7 regional operation centers serving over 170 countries. In 2024, the Huawei Developer Alliance exceeded 6.8 million developers, with a 45% year-on-year increase in app distribution.

Euro Tech Holdings Company Limited Announces Stock Repurchase Program

HONG KONG, Feb. 20, 2025 /PRNewswire/ — Euro Tech Holdings Company Limited (Nasdaq: CLWT) (the “Company”) today announced that its Board of Directors (the “Board”) has approved a program to repurchase up to 350,000 shares of its issued and outstanding ordinary shares for an aggregate purchase price of up to $500,000. This gives the Company the ability to repurchase its shares in the open market or through negotiated or block transactions from time to time based on market and business conditions over the next 12 months.

The Board has a high degree of confidence in the Company’s future and believes that this expectation is not reflected in the current stock price of the Company’s shares, which is also much lower than the Company’s net asset value on a per share basis.

Forward-Looking Statement

This release contains forward-looking statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 and may be governed by terms such as “will,” “expect,” “would,” “anticipate,” “future,” “intend,” “plan,” “believe,” “estimate,” “potential,” “continue,” “in progress,” “goal,” “guidance expectations” and similar statements are identified. Forward-looking statements contained in this release relate to, among other things, the Company’s ongoing compliance with the Holding Foreign Companies Accountable Act (the “HFCAA”). Readers should not place undue reliance on such forward-looking statements, which are based upon the Company’s beliefs and assumptions as of the date of this release. The actual results could differ materially due to risk factors and other items described in more detail in the “Risk Factors” section of the Company’s Annual Reports and other filings filed with the U.S. Securities and Exchange Commission (the “SEC”) (copies of which may be obtained at www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.